Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorthe B Berthelsen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Clinical Epidemiology|April 6, 2020
Controversy and Debate on Meta-epidemiology. Paper 3: Causal inference from meta-epidemiology: a reasonable goal, or wishful thinking?Robin Christensen, Dorthe B Berthelsen
Ugeskrift for Laeger|September 26, 2024
Dorthe B Berthelsen, Linea Rishøj Thorlacius, Bente Villumsen, et al.
Scandinavian Journal of Caring Sciences|March 25, 2025
Improving Rehabilitation for People With Type 2 Diabetes: Experiences From a Qualitative Study in a Municipal SettingMarie Konge Nielsen, Emilie Marie Andrés, Jette Thuesen, et al.
Journal of Clinical Epidemiology|March 29, 2020
Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measureDorthe B Berthelsen, Elisabeth Ginnerup-Nielsen, Carsten Juhl, et al.
Journal of Clinical Epidemiology|March 9, 2026
Harm Outcomes Applicable for Most Meta-Analyses of Randomized Trials of Biomedical Interventions: A Key Concept in Clinical EpidemiologyRobin Christensen, Dorthe B Berthelsen, Peter Tugwell, et al.
JMIR Research Protocols|September 3, 2021
Perceived Benefits, Barriers, and Facilitators of a Digital Patient-Reported Outcomes Tool for Routine Diabetes Care: Protocol for a National, Multicenter, Mixed Methods Implementation StudySøren Eik Skovlund, Antonio Nicolucci, Nina Balk-Møller, et al.
Rheumatology (Oxford, England)|April 13, 2024
'I couldn't carry on taking a drug like that': a qualitative study of patient perspectives on side effects from rheumatology drugsDorthe B Berthelsen, Sabrina M Nielsen, Marianne U Rasmussen, et al.
Seminars in Arthritis and Rheumatism|April 25, 2026
Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT studyDorthe B Berthelsen, Tobias Haugegaard, Mohammed M Kamso, et al.
The Journal of Rheumatology|May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology TrialsLouise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism|February 10, 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellowsLara S Chapman, Ayano Kelly, Erin Balay-Dustrude, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Clinical Epidemiology|April 6, 2020
Controversy and Debate on Meta-epidemiology. Paper 3: Causal inference from meta-epidemiology: a reasonable goal, or wishful thinking?Robin Christensen, Dorthe B Berthelsen
Ugeskrift for Laeger|September 26, 2024
Dorthe B Berthelsen, Linea Rishøj Thorlacius, Bente Villumsen, et al.
Scandinavian Journal of Caring Sciences|March 25, 2025
Improving Rehabilitation for People With Type 2 Diabetes: Experiences From a Qualitative Study in a Municipal SettingMarie Konge Nielsen, Emilie Marie Andrés, Jette Thuesen, et al.
Journal of Clinical Epidemiology|March 29, 2020
Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measureDorthe B Berthelsen, Elisabeth Ginnerup-Nielsen, Carsten Juhl, et al.
Journal of Clinical Epidemiology|March 9, 2026
Harm Outcomes Applicable for Most Meta-Analyses of Randomized Trials of Biomedical Interventions: A Key Concept in Clinical EpidemiologyRobin Christensen, Dorthe B Berthelsen, Peter Tugwell, et al.
JMIR Research Protocols|September 3, 2021
Perceived Benefits, Barriers, and Facilitators of a Digital Patient-Reported Outcomes Tool for Routine Diabetes Care: Protocol for a National, Multicenter, Mixed Methods Implementation StudySøren Eik Skovlund, Antonio Nicolucci, Nina Balk-Møller, et al.
Rheumatology (Oxford, England)|April 13, 2024
'I couldn't carry on taking a drug like that': a qualitative study of patient perspectives on side effects from rheumatology drugsDorthe B Berthelsen, Sabrina M Nielsen, Marianne U Rasmussen, et al.
Seminars in Arthritis and Rheumatism|April 25, 2026
Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT studyDorthe B Berthelsen, Tobias Haugegaard, Mohammed M Kamso, et al.
The Journal of Rheumatology|May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology TrialsLouise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism|February 10, 2024
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellowsLara S Chapman, Ayano Kelly, Erin Balay-Dustrude, et al.
Pageof 2